5-Flurouracil

Phase 3

5-Flurouracil is one of 7 therapeutic programs targeting Squamous Cell Carcinoma of Head and Neck. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Squamous Cell Carcinoma of Head and NeckRecruiting

Squamous Cell Carcinoma of Head and NeckPhase 3

Recruiting

Competition

Competitive Landscape

6 competitors in Squamous Cell Carcinoma of Head and Neck

#DrugCompanyPhaseTrials

Rybrevant

Johnson & Johnson

Phase 3

2 2

Keytruda

Merck & Co.

Phase 3

2 3

Paraplatin

AAvyxa

Phase 3

3 4

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

2 5

Taxol

Teva

Phase 1

2 6

5-Flurouracil

Johnson & Johnson

Phase 3

1 7

JNJ-90301900

JJohnson & Johnson Enterprise Innovation Inc.

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2029

Phase 3Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07276399

Clinical

Trials by Indication[1]

Squamous Cell Carcinoma of Head and Neck1 trial

A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants With Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Recruiting· Johnson & Johnson logo

Johnson & Johnson·Phase 3·NCT07276399·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for 5-Flurouracil. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for 5-Flurouracil. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Johnson & Johnson company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: Johnson & Johnson

5-Flurouracil

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q2 2029

Trials by Indication[1]

Squamous Cell Carcinoma of Head and Neck1 trial

References

Drug Info

Quick Facts

Related News